Literature DB >> 8777993

Structure-function relationships within peripheral nerves in diabetic neuropathy: the hydration hypothesis.

R P Eaton1, C Qualls, J Bicknell, W L Sibbitt, M K King, R H Griffey.   

Abstract

To define the quantitative relationship between peripheral nerve structure and function imposed by endoneurial oedema in the diabetic state, we determined values for sural nerve hydration structure as measured by magnetic resonance spectroscopy, and for neurological function with scores for nerve conduction properties (NCV-score), neuropathic symptoms (NS-score), and examination signs (NE-score). The coefficient of sural nerve hydration was elevated to 30 +/- 6% (p < 0.05) in 79 symptomatic neuropathic diabetic subjects with an average of 15 years of diabetes mellitus, compared to a value of 25 +/- 3% in 72 non-diabetic control subjects. In contrast, in 75 asymptomatic diabetic subjects with an average of 6 additional years of diabetes, the mean hydration coefficient was only 28 +/- 5% (p < 0.05). A nerve hyperhydration state was identified with a prevalence of 25% within the asymptomatic group characterized by nerve hydration greater than the 95th percentile, early changes in nerve electrophysiology and neurological examination, but with no symptomatology of neuropathy. Stratification of the symptomatic neuropathic group by worsening nerve electrophysiology, demonstrates a coincident deterioration in neurological examination (RR = 5.39 at maximum NCV-score), and neuropathy symptomatology (RR = 4.80 at maximum NE-score). The present data are consistent with the hypothesis that endoneurial oedema initiates deterioration sequentially in nerve electrophysiology, followed by abnormal findings on neurological examination, preceding the patient's final perception of symptomatic stocking glove peripheral diabetic neuropathy.

Entities:  

Mesh:

Year:  1996        PMID: 8777993     DOI: 10.1007/bf00400675

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  41 in total

1.  Sural nerve oxygen tension in diabetes.

Authors:  P G Newrick; A J Wilson; J Jakubowski; A J Boulton; J D Ward
Journal:  Br Med J (Clin Res Ed)       Date:  1986-10-25

2.  The collagen hydration hypothesis: a new paradigm for the secondary complications of diabetes mellitus.

Authors:  R P Eaton
Journal:  J Chronic Dis       Date:  1986

Review 3.  The sorbitol pathway and the complications of diabetes.

Authors:  K H Gabbay
Journal:  N Engl J Med       Date:  1973-04-19       Impact factor: 91.245

4.  Characterization of the human aldose reductase gene promoter.

Authors:  K Wang; K M Bohren; K H Gabbay
Journal:  J Biol Chem       Date:  1993-07-25       Impact factor: 5.157

5.  Acute onset of diabetic pathological changes in transgenic mice with human aldose reductase cDNA.

Authors:  T Yamaoka; C Nishimura; K Yamashita; M Itakura; T Yamada; J Fujimoto; Y Kokai
Journal:  Diabetologia       Date:  1995-03       Impact factor: 10.122

6.  Regeneration and repair of myelinated fibers in sural-nerve biopsy specimens from patients with diabetic neuropathy treated with sorbinil.

Authors:  A A Sima; V Bril; V Nathaniel; T A McEwen; M B Brown; S A Lattimer; D A Greene
Journal:  N Engl J Med       Date:  1988-09-01       Impact factor: 91.245

7.  Effect of hyperglycemia and the aldose reductase inhibitor tolrestat on sural nerve biochemistry and morphometry in advanced diabetic peripheral polyneuropathy. The Tolrestat Study Group.

Authors:  A A Sima; D A Greene; M B Brown; T C Hohman; D Hicks; G J Graepel; W J Bochenek; M Beg; B Gonen
Journal:  J Diabetes Complications       Date:  1993 Jul-Sep       Impact factor: 2.852

8.  Sural nerve water in vivo in normal humans measured by magnetic resonance spectroscopy: relation to age, height, gender, and neurological profile.

Authors:  R P Eaton; W L Sibbitt; J M Bicknell; M K King; R H Griffey; R R Sibbitt
Journal:  Muscle Nerve       Date:  1993-03       Impact factor: 3.217

9.  Diabetic neuropathy. Structural analysis of nerve hydration by magnetic resonance spectroscopy.

Authors:  R H Griffey; R P Eaton; R R Sibbitt; W L Sibbitt; J M Bicknell
Journal:  JAMA       Date:  1988-11-18       Impact factor: 56.272

10.  An (A-C)n dinucleotide repeat polymorphic marker at the 5' end of the aldose reductase gene is associated with early-onset diabetic retinopathy in NIDDM patients.

Authors:  B C Ko; K S Lam; N M Wat; S S Chung
Journal:  Diabetes       Date:  1995-07       Impact factor: 9.461

View more
  5 in total

1.  MR T2 value of the tibial nerve can be used as a potential non-invasive and quantitative biomarker for the diagnosis of diabetic peripheral neuropathy.

Authors:  Dongye Wang; Chuan Wang; Xiaohui Duan; Zehong Yang; Zhiqiang Bai; Huijun Hu; Li Yan; Jun Shen
Journal:  Eur Radiol       Date:  2017-10-16       Impact factor: 5.315

2.  Relation between retrobulbar circulation and progression of diabetic retinopathy.

Authors:  G Dimitrova; S Kato; H Yamashita; Y Tamaki; M Nagahara; H Fukushima; S Kitano
Journal:  Br J Ophthalmol       Date:  2003-05       Impact factor: 4.638

3.  Assessment of diabetic peripheral neuropathy in streptozotocin-induced diabetic rats with magnetic resonance imaging.

Authors:  Dongye Wang; Xiang Zhang; Liejing Lu; Haojiang Li; Fang Zhang; Yueyao Chen; Jun Shen
Journal:  Eur Radiol       Date:  2014-09-10       Impact factor: 5.315

Review 4.  Homeostatic regulation of the endoneurial microenvironment during development, aging and in response to trauma, disease and toxic insult.

Authors:  Andrew P Mizisin; Ananda Weerasuriya
Journal:  Acta Neuropathol       Date:  2010-12-07       Impact factor: 17.088

5.  Magnetic Resonance Imaging as a Biomarker in Diabetic and HIV-Associated Peripheral Neuropathy: A Systematic Review-Based Narrative.

Authors:  Matthew C Evans; Charles Wade; David Hohenschurz-Schmidt; Pete Lally; Albert Ugwudike; Kamal Shah; Neal Bangerter; David J Sharp; Andrew S C Rice
Journal:  Front Neurosci       Date:  2021-09-21       Impact factor: 4.677

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.